FindTrial
Sign In

Surveillance of HIV, Hepatitis B and Hepatitis C, and related (risk) behavior among hard drug users under addictive care at Mondriaan centre in Heerlen

Surveillance of HIV, Hepatitis B and Hepatitis C, and related (risk) behavior among hard drug users under addictive care at Mondriaan centre in Heerlen - Surveillance of HIV, hepatitis B and C among hard drug users

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33271
Enrollment
100
Registered
2009-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS Hepatitis HIV infectious diseases jaundice

Interventions

None listed

Sponsors

RIVM
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Individuals aged 18 and above - Individuals who are under care at Mondriaan outpatient clinic for drug addicts in Heerlen - Individuals who have used hard drugs at least once a week throughout the last 6 months. Hard drugs are defined as heroin, coke, opium, methadone, LSD, amphetamine (speed), or XTC - Both injecting and non-injecting hard drug users - Individuals with a signed written informed consent for participation in the study

Exclusion criteria

Exclusion criteria: - Individuals under the age of 18 years - Individuals without written informed consent - Individuals who have participated in the study before - Individuals who have not used hard drugs more than once a week throughout the last 6 months

Design outcomes

Primary

MeasureTime frame
The primary outcome of interest is to assess in the prevalence of viral infectious diseases (HIV, hepatitis C and hepatitis B) among hard drug users in care at Mondriaan carecentre for addiction in Heerlen.—

Secondary

MeasureTime frame
Secondary outcomes encloses understanding of potential associations for infectious diseases, and (related) risk factors like drug and sexual behavior, demographics, mobility of addicts, detention, sexual transmitted diseases and the use of Methadone.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)